A recent Australian study has revealed that Parkinson’s disease presents with a far broader range of non-motor symptoms than previously understood, with a complex interplay between age, genetics, and environmental factors. The research highlights significant differences in how the disease manifests between men and women, underscoring the require for earlier diagnosis and more personalized treatment approaches. Understanding these nuances is crucial as Parkinson’s disease is a growing global health concern.
Parkinson’s disease is the fastest-growing neurological disorder worldwide, affecting more than 10 million people globally.
Currently, approximately 150,000 Australians are living with the condition, with 50 novel cases diagnosed daily. Projections indicate that the number of individuals with Parkinson’s disease will more than triple by 2050 compared to 2020.
Despite the profound impact of Parkinson’s disease on patients and their families, and the substantial economic burden – exceeding AUD $10 billion annually in Australia – much remains unknown about its onset and progression. A large-scale study, involving nearly 11,000 Australians with Parkinson’s disease, provides important insights into symptoms, risk factors, and how these aspects differ between sexes.
The study found that Parkinson’s disease is 1.5 times more common in men, with 63 percent of participants identifying as male. However, women tended to experience the onset of symptoms at a younger age, with an average of 63.7 years compared to 64.4 years for men. Diagnosis also occurred earlier in women, at a mean age of 67.6 years versus 68.1 years for men.
Women were also more likely to report experiencing pain (70 percent versus 63 percent) and falls (45 percent versus 41 percent). Conversely, men reported more changes in memory (67 percent versus 61 percent) and impulsive behaviors, particularly related to sexual behavior (56 percent versus 19 percent). It’s important to note that most participants did not exhibit significant impulsivity.
Parkinson’s disease is a progressive disorder where symptoms worsen over time. It begins with the death of cells that produce dopamine in a part of the brain known as the substantia nigra, accompanied by other changes within the brain. The disease is often associated with a variety of less-recognized non-motor symptoms, including mood changes, difficulties with memory and cognition – such as slowed thinking, challenges with planning or multitasking, and problems with attention or concentration – sleep disturbances, and dysfunction of the autonomic nervous system, leading to issues like constipation, low blood pressure, and bladder problems.
Though these non-motor symptoms are sometimes referred to as “hidden” symptoms of Parkinson’s disease, their negative impact on quality of life often surpasses that of the motor symptoms. The study confirmed the prevalence of these non-motor symptoms, with 52 percent of participants reporting a loss of smell, 65 percent experiencing changes in memory, 66 percent reporting pain, and 66 percent experiencing dizziness.
Approximately 25 percent of participants had a family history of Parkinson’s disease. However, only 10 to 15 percent of cases are directly caused by or strongly linked to mutations in specific genes. Families often share not only genes but also environmental factors, such as exposure to pesticides and traumatic brain injuries, which can increase the risk of developing Parkinson’s disease.
